Supernus Pharmaceuticals
SUPN
SUPN
247 hedge funds and large institutions have $1.72B invested in Supernus Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 91 increasing their positions, 89 reducing their positions, and 38 closing their positions.
Holders
247
Holders Change
-9
Holders Change %
-3.52%
% of All Funds
3.9%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
29
Increased
91
Reduced
89
Closed
38
Calls
$2.54M
Puts
$343K
Net Calls
+$2.19M
Net Calls Change
-$634K
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$151M |
| 2 |
BG
2
Bellevue Group
Kuesnacht,
Switzerland
|
$19.5M |
| 3 |
3
BlackRock
New York
|
$299M |
| 4 |
4
Pacer Advisors
Malvern,
Pennsylvania
|
$13.5M |
| 5 |
CAM
5
Congress Asset Management
Boston,
Massachusetts
|
$23.1M |
